Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mimedx (MDXG) Consolidated Net Income (2016 - 2026)

Mimedx's Consolidated Net Income history spans 15 years, with the latest figure at -$10.9 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income changed N/A to -$10.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$10.9 million, a 5014.03% decrease, with the full-year FY2024 number at $421000.0, up 104.57% from a year prior.
  • Consolidated Net Income hit -$10.9 million in Q1 2026 for Mimedx, down from $217000.0 in the prior quarter.
  • Over the last five years, Consolidated Net Income for MDXG hit a ceiling of $9.8 million in Q4 2022 and a floor of -$10.9 million in Q2 2022.
  • Historically, Consolidated Net Income has averaged -$3.3 million across 4 years, with a median of -$1.7 million in 2023.
  • The widest YoY moves for Consolidated Net Income: up 4839.7% in 2022, down 510.91% in 2022.
  • Tracing MDXG's Consolidated Net Income over 4 years: stood at $9.8 million in 2022, then tumbled by 77.73% to $2.2 million in 2023, then plummeted by 90.09% to $217000.0 in 2024, then crashed by 5104.61% to -$10.9 million in 2026.
  • Business Quant data shows Consolidated Net Income for MDXG at -$10.9 million in Q1 2026, $217000.0 in Q3 2024, and $4000.0 in Q2 2024.